These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 790952)

  • 1. System for clinical pharmacokinetic monitoring of theophylline therapy.
    Koup JR; Schentag JJ; Vance JW; Kuritzky PM; Pyszczynski DR; Jusko WJ
    Am J Hosp Pharm; 1976 Sep; 33(9):949-56. PubMed ID: 790952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Chiou method for determining theophylline dosages.
    Johnson MH; Burkle WS
    Clin Pharm; 1984; 3(2):174-8. PubMed ID: 6723223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theophylline: constant-rate infusion predictions.
    Mesquita CA; Sahebjami H; Imhoff T; Thomas JP; Myre SA
    Ther Drug Monit; 1984; 6(2):157-63. PubMed ID: 6740734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of theophylline clearance using condition correction factors.
    Haumschild MJ; Murphy JE
    Clin Pharm; 1985; 4(1):59-64. PubMed ID: 3971684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of 11 methods for predicting theophylline dose.
    Rodvold KA; Paloucek FP; Zell M
    Clin Pharm; 1986 May; 5(5):403-8. PubMed ID: 3720210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of theophylline clearance in determining chronic oral dosage regimens.
    Slotfeldt ML; Johnson CE; Grambau G; Weg JG
    Am J Hosp Pharm; 1979 Jan; 36(1):66-8. PubMed ID: 758787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early estimate of theophylline clearance during intravenous infusion.
    Rizzo A; Mirabella A; Ferrara G; Mangiacavallo A; Bonanno A; Bonsignore G
    Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravenous theophylline: adaptation of dosage to blood theophylline levels at admission and to clearance].
    Laaban JP; Dupeyron JP; Guyon F; Drieu L; Rochemaure J; Fabiani P
    Ann Med Interne (Paris); 1986; 137(5):415-9. PubMed ID: 3813276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
    Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
    Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonlinear regression program to individualize oral theophylline dosage.
    Bauer LA; Black DJ; Koup JR
    Clin Pharm; 1984; 3(3):288-90. PubMed ID: 6547379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion.
    Lau AH; O'Connor T; Lam G; Lui CY; Al-Bazzaz FJ; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety: cimetidine and concomitant theophylline or warfarin--drug interactions and their implications.
    Frank WO
    Clin Ther; 1986; 8 Suppl A():57-68. PubMed ID: 2878729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of the single point method for theophylline maintenance dose prediction.
    Abad J; Pastor A; Prieto L; Palop J; Jiménez Torres V; Castro J
    Allergol Immunopathol (Madr); 1987; 15(6):355-9. PubMed ID: 3445876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of the laboratory in optimizing anti-asthma therapy with theophylline].
    Snidero M
    Quad Sclavo Diagn; 1987 Mar; 23(1):72-91. PubMed ID: 3327089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics in drug therapy II: Applications of clinical pharmacokinetics in the assessment of theophylline therapy.
    Floyd RA; Cohen JL
    Am J Hosp Pharm; 1977 Apr; 34(4):402-7. PubMed ID: 871124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetic analysis of theophylline in serum and saliva.
    Trnavská Z; Rejholec V; Elis J; Spicák V
    Int J Clin Pharmacol Res; 1987; 7(5):329-35. PubMed ID: 3667005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of pharmacokinetic profile in evaluating patients with repeatedly low theophylline concentrations.
    Georgitis JW; Szefler SJ; Baswell B; Shen DD
    Ann Allergy; 1984 Sep; 53(3):231-5. PubMed ID: 6476482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adequacy of recommended aminophylline loading doses in children.
    Maxwell-Rubin M; Paap CM; Godley PJ
    Am J Hosp Pharm; 1994 Jul; 51(13):1667-71. PubMed ID: 7942891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a pharmacokinetic method for establishing doses of aminophylline to treat acute bronchospasm.
    Pancorbo S; Davies S; Raymond JL
    Am J Hosp Pharm; 1981 Jun; 38(6):851-6. PubMed ID: 7246557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
    Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
    Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.